Commerce Bancshares, Inc. (CBSH)’s Vice Chairman Jonathan Kemper Sold 46030 shares of the Company; Sands Capital Management Trimmed By $123.38 Million Its Alexion Pharmaceuticals (ALXN) Stake

Commerce Bancshares, Inc. (NASDAQ:CBSH) Logo

Sands Capital Management Llc decreased Alexion Pharmaceuticals Inc (ALXN) stake by 24.41% reported in 2018Q1 SEC filing. Sands Capital Management Llc sold 1.11M shares as Alexion Pharmaceuticals Inc (ALXN)’s stock declined 2.96%. The Sands Capital Management Llc holds 3.44 million shares with $383.60M value, down from 4.55M last quarter. Alexion Pharmaceuticals Inc now has $26.35 billion valuation. The stock increased 0.71% or $0.84 during the last trading session, reaching $118.42. About 559,756 shares traded. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has risen 19.53% since June 13, 2017 and is uptrending. It has outperformed by 6.96% the S&P500. Some Historical ALXN News: ; 11/04/2018 – ALEXION PHARMACEUTICALS INC ALXN.O SAYS ALEXION INTENDS TO FINANCE ACQUISITION THROUGH CASH ON HAND; 11/04/2018 – Alexion Agrees to Acquire Wilson Therapeutics; 11/04/2018 – ALEXION PHARMACEUTICALS INC ALXN.O SAYS ALEXION WILL ACQUIRE WILSON THERAPEUTICS THROUGH A TENDER OFFER; 26/04/2018 – Alexion Pharmaceuticals Sees FY Adj EPS $6.60-Adj EPS $6.80; 15/03/2018 – ALEXION PHARMACEUTICALS INC ALXN.O : CREDIT SUISSE RAISES TARGET PRICE TO $149 FROM $147; 26/04/2018 – ALEXION PHARMACEUTICALS INC – EXPECTS TO INCUR ADDITIONAL RESTRUCTURING AND RELATED EXPENSES OF APPROXIMATELY $15 MLN TO $80 MLN IN 2018; 15/03/2018 – Alexion Pharmaceuticals ALXN1210 Achieved Non-Inferiority to Soliris on Co-Primary Endpoints of Transfusion Avoidance and Lactate Dehydrogenase Normalization; 20/04/2018 – BRAZIL TO BE ABLE TO PRODUCE GENERIC SOLIRIS: ATTORNEY GENERAL; 11/04/2018 – Alexion to Buy Wilson for $790 Million for Rare Drug (Correct); 02/04/2018 – Abeona Therapeutics Names Former Alexion Executive as CEO

Commerce Bancshares, Inc. operates as the holding firm for Commerce Bank that provides retail, mortgage banking, corporate, investment, trust, and asset management services and products to individuals and businesses. The company has market cap of $6.95 billion. It operates through three divisions: Consumer, Commercial, and Wealth. It has a 20.57 P/E ratio. The Consumer segment offers various banking services and products, including consumer deposits; consumer loans, such as automobile, motorcycle, marine, tractor/trailer, recreational vehicle, fixed rate and revolving home equity, and other consumer loans; real estate loans; indirect and other consumer financing; personal mortgage banking; and consumer debit and credit bank cards, as well as provides online, mobile, and telephone banking services.

Among 11 analysts covering Commerce Bancshares (NASDAQ:CBSH), 0 have Buy rating, 2 Sell and 9 Hold. Therefore 0 are positive. Commerce Bancshares has $6700 highest and $40 lowest target. $62.50’s average target is -4.14% below currents $65.2 stock price. Commerce Bancshares had 41 analyst reports since October 15, 2015 according to SRatingsIntel. Bank of America downgraded Commerce Bancshares, Inc. (NASDAQ:CBSH) on Tuesday, May 15 to “Sell” rating. On Tuesday, April 17 the stock rating was maintained by Morgan Stanley with “Underweight”. The firm earned “Hold” rating on Tuesday, October 10 by Jefferies. The stock of Commerce Bancshares, Inc. (NASDAQ:CBSH) earned “Sell” rating by Keefe Bruyette & Woods on Thursday, January 18. The stock of Commerce Bancshares, Inc. (NASDAQ:CBSH) earned “Hold” rating by Barclays Capital on Tuesday, January 2. The stock has “Hold” rating by Piper Jaffray on Thursday, July 13. Keefe Bruyette & Woods maintained Commerce Bancshares, Inc. (NASDAQ:CBSH) rating on Tuesday, October 3. Keefe Bruyette & Woods has “Sell” rating and $49.0 target. The firm earned “Hold” rating on Wednesday, April 18 by Jefferies. As per Thursday, October 12, the company rating was maintained by Piper Jaffray. On Monday, February 26 the stock rating was upgraded by Keefe Bruyette & Woods to “Hold”.

The stock decreased 0.29% or $0.19 during the last trading session, reaching $65.2. About 107,701 shares traded. Commerce Bancshares, Inc. (NASDAQ:CBSH) has risen 25.07% since June 13, 2017 and is uptrending. It has outperformed by 12.50% the S&P500. Some Historical CBSH News: ; 19/04/2018 – DJ Pacific Commerce Bancorp, Inst Holders, 1Q 2018 (PCBC); 09/03/2018 The Law Offices of Vincent Wong Notifies Investors of an Investigation into Pacific Commerce Bancorp in Connection with the Sal; 01/05/2018 – Acquisition of Commerce Bank of Temecula Valley Completed; 03/04/2018 – Aircraft Owners and Pilots Association and Commerce Bank Introduce AOPA World Mastercard® for Pilots; 19/03/2018 – Commerce Bank Recognized by Greenwich Associates with Eight Greenwich Excellence Awards

Analysts await Commerce Bancshares, Inc. (NASDAQ:CBSH) to report earnings on July, 12. They expect $0.88 EPS, up 23.94% or $0.17 from last year’s $0.71 per share. CBSH’s profit will be $93.80 million for 18.52 P/E if the $0.88 EPS becomes a reality. After $0.92 actual EPS reported by Commerce Bancshares, Inc. for the previous quarter, Wall Street now forecasts -4.35% negative EPS growth.

More important recent Commerce Bancshares, Inc. (NASDAQ:CBSH) news were published by: Businesswire.com which released: “Commerce Bancshares, Inc. to Participate in Morgan Stanley’s Financials Conference, June 12-13, 2018” on June 08, 2018, also Bizjournals.com published article titled: “As another Kemper steps down, Commerce Bank shuffles its leadership”, Streetinsider.com published: “Commerce Bancshares (CBSH) PT Raised to $64 at FIG Partners” on June 05, 2018. More interesting news about Commerce Bancshares, Inc. (NASDAQ:CBSH) was released by: Nasdaq.com and their article: “Report: Exploring Fundamental Drivers Behind Micronet Enertec Technologies, Everbridge, Visteon, Commerce ..” with publication date: May 17, 2018.

The Commerce Bancshares Inc’s Vice Chairman, Jonathan Kemper, an insider sold – 46,030 Commerce Bancshares Inc’s shares, based on the stock price per share of $65.3 for each share. These shares had a value of around $3,005,602 US Dollars. Published June 12, 2018, you can read more about the transaction by accessing the following original report here. Obviously, the sell gained attention, as Mr. Jonathan at the moment has 1.46 million shares, accounting for 1.37% of the company’s stock market capitalization.

Since January 29, 2018, it had 0 insider purchases, and 28 sales for $20.33 million activity. FOSTER SARA E sold 1,168 shares worth $67,744. Roller David L. sold $9,863 worth of stock. Callahan Daniel D. also sold $62,074 worth of Commerce Bancshares, Inc. (NASDAQ:CBSH) on Monday, February 12. $84,148 worth of Commerce Bancshares, Inc. (NASDAQ:CBSH) shares were sold by ABERDEEN JEFFERY D. Handy John K also sold $466,210 worth of Commerce Bancshares, Inc. (NASDAQ:CBSH) shares. On Tuesday, April 17 the insider KEMPER DAVID W sold $530,659. Shares for $35,308 were sold by PETRIE MICHAEL J.

Investors sentiment decreased to 1.07 in Q1 2018. Its down 1.64, from 2.71 in 2017Q4. It dived, as 16 investors sold Commerce Bancshares, Inc. shares while 91 reduced holdings. 34 funds opened positions while 81 raised stakes. 67.86 million shares or 3.53% more from 65.55 million shares in 2017Q4 were reported. Northwestern Mutual Wealth Management, Wisconsin-based fund reported 4,293 shares. Stone Ridge Asset has 0.02% invested in Commerce Bancshares, Inc. (NASDAQ:CBSH). 9,091 were reported by Cibc Asset Mgmt Inc. Ballentine Prtnrs Llc accumulated 9,282 shares or 0.03% of the stock. Glenmede Na holds 0% or 14,441 shares. Ny State Common Retirement Fund reported 354,521 shares. Moreover, State Of Alaska Department Of Revenue has 0.01% invested in Commerce Bancshares, Inc. (NASDAQ:CBSH). Regions Corporation owns 13,615 shares. Dekabank Deutsche Girozentrale holds 0.02% or 58,700 shares in its portfolio. Raymond James & Associate has 235,408 shares for 0.03% of their portfolio. Robeco Institutional Asset Mgmt Bv reported 1,649 shares. Gw Henssler And Associate Limited has 0.03% invested in Commerce Bancshares, Inc. (NASDAQ:CBSH). Us Bankshares De reported 159,380 shares stake. Thomas Story Son Limited Liability Company accumulated 19,139 shares or 0.67% of the stock. Earnest Prtnrs Lc holds 89 shares or 0% of its portfolio.

Analysts await Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) to report earnings on July, 26. They expect $1.47 EPS, up 12.21% or $0.16 from last year’s $1.31 per share. ALXN’s profit will be $327.08M for 20.14 P/E if the $1.47 EPS becomes a reality. After $1.53 actual EPS reported by Alexion Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -3.92% negative EPS growth.

Among 29 analysts covering Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), 25 have Buy rating, 0 Sell and 4 Hold. Therefore 86% are positive. Alexion Pharmaceuticals Inc. had 111 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Neutral” rating by Wedbush given on Friday, October 28. Morgan Stanley maintained the stock with “Overweight” rating in Friday, February 9 report. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has “Buy” rating given on Friday, October 28 by Goldman Sachs. On Friday, October 2 the stock rating was upgraded by Morgan Stanley to “Overweight”. The stock has “Overweight” rating by Morgan Stanley on Thursday, May 25. Credit Suisse maintained it with “Outperform” rating and $154 target in Tuesday, June 5 report. The stock has “Buy” rating by Stifel Nicolaus on Tuesday, September 12. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) earned “Outperform” rating by Robert W. Baird on Monday, December 18. Credit Suisse initiated the stock with “Neutral” rating in Wednesday, January 20 report. The stock has “Strong Buy” rating by Raymond James on Tuesday, September 1.

Sands Capital Management Llc increased Allergan Plc stake by 14,985 shares to 45,058 valued at $7.58M in 2018Q1. It also upped Taiwan Semiconductor Mfg Ltd (NYSE:TSM) stake by 155,131 shares and now owns 2.41M shares. Ctrip Com Intl Ltd (NASDAQ:CTRP) was raised too.

More important recent Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) news were published by: 247Wallst.com which released: “Short Sellers Up the Ante For Major Biotechs” on June 12, 2018, also Streetinsider.com published article titled: “Alexion Pharma (ALXN), Complement Pharma Announce Pact to Co-Develop Pre-Clinical Complement Inhibitor for …”, Schaeffersresearch.com published: “2 Biotech Stocks That Could Blast Off This Summer” on June 04, 2018. More interesting news about Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) was released by: Investorplace.com and their article: “10 Stocks That Are Screaming Buys Right Now” with publication date: June 12, 2018.

Since January 2, 2018, it had 1 insider purchase, and 12 selling transactions for $3.41 million activity. $147,865 worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) was sold by Moriarty John B on Monday, February 5. $1.21 million worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) was bought by COUGHLIN CHRISTOPHER J. $76,805 worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) was sold by Wagner Heidi L on Monday, February 5. Goff Brian had sold 1,651 shares worth $192,028 on Tuesday, February 6. 2,119 Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares with value of $248,474 were sold by O’Neill Julie. On Tuesday, February 6 the insider Clancy Paul J sold $707,048. Shares for $169,696 were sold by Franchini Indrani Lall.

Investors sentiment decreased to 1 in Q1 2018. Its down 0.03, from 1.03 in 2017Q4. It turned negative, as 43 investors sold ALXN shares while 184 reduced holdings. 60 funds opened positions while 167 raised stakes. 200.94 million shares or 1.68% less from 204.38 million shares in 2017Q4 were reported. Geode Cap Lc invested 0.09% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Swiss Financial Bank accumulated 716,841 shares or 0.1% of the stock. Louisiana State Employees Retirement holds 0.07% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) or 13,500 shares. Commerzbank Aktiengesellschaft Fi owns 111,425 shares or 0.14% of their US portfolio. Old Mutual Customised Solutions (Proprietary) Ltd invested 0.04% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Fiera Capital Corp invested 0% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Highland Mngmt LP accumulated 6,950 shares. The Luxembourg-based Pictet Cie (Europe) Sa has invested 0.11% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Retirement System Of Alabama stated it has 105,900 shares or 0.06% of all its holdings. Tobam invested in 0.54% or 117,676 shares. State Street owns 0.09% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 9.11M shares. Proshare Limited Liability Co has 0.19% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Van Eck Assocs has invested 0.1% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). 63 are owned by Ftb Advsr Incorporated. Pillar Pacific Cap Management Ltd reported 19,605 shares.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Institutional Positions Chart